文献速递慢阻肺

客观测量的体力活动作为慢阻肺临床试验结局指标

Objectively Measured Physical Activity as a COPD Clinical Trial Outcome.
PubMed 文献 · Chest · 2021-07-01

结果显示,行为改变、移动健康、康复运动、支气管扩张、肺减容等干预对客观体力活动的影响不一,仅少数研究显示每日步数增加超过600-1100步的最小重要变化,提示提升体力活动水平仍具挑战。

要点

  • 不同干预(行为、移动健康、康复、支气管扩张、肺减容)对体力活动效果异质性大。
  • 仅少数研究显示每日步数增加超过600-1100步的最小重要变化。

核心结论

  • 仅约三分之一的慢阻肺临床试验在客观体力活动评估上满足预设标准。
  • 即使干预类型相似,各研究对体力活动的影响仍存在差异。
  • 提升慢阻肺患者体力活动水平具有挑战性,仅少数研究显示每日步数增加超过600-1100步。

研究设计与样本

  • 本研究为叙述性综述,由COPD生物标志物资格联盟(CBQC)工作组检索三个科学数据库。
  • 纳入标准基于科学文献和专家共识:测量≥7天、≥4个有效日、每日监测≥8小时。

主要发现

  • 各研究结果总体变异较大,反映了研究特征和结局指标的巨大差异。
  • 仅少数研究显示每日步数增加超过提出的最小重要变化值600至1100步。
  • 即使研究相似干预措施,对体力活动的影响仍不一致。

关键数值与推荐

  • 体力活动评估的最低方法学质量要求:测量≥7天、≥4个有效日、每日监测≥8小时。
  • 最小重要变化参考范围为每日步数增加600至1100步。

临床怎么用

  • 解读慢阻肺临床试验的体力活动结局时,应关注评估方法是否满足最低质量标准(≥7天测量、≥4个有效日、每日≥8小时监测)。
  • 评估干预对体力活动的影响时,可参考每日步数增加600-1100步作为最小重要变化阈值。
  • 鉴于现有研究结果异质性大,临床决策应结合具体干预类型和患者特征,不宜一概而论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Reduced physical activity is common in COPD and is associated with poor outcomes. Physical activity is therefore a worthy target for intervention in clinical trials; however, trials evaluating physical activity have used heterogeneous methods. RESEARCH QUESTION: What is the available evidence on the efficacy and/or effectiveness of various interventions to enhance objectively measured physical activity in patients with COPD, taking into account the minimal preferred methodologic quality of physical activity assessment? STUDY DESIGN AND METHODS: In this narrative review, the COPD Biomarker Qualification Consortium (CBQC) task force searched three scientific databases for articles that reported the effect of an intervention on objectively measured physical activity in COPD. Based on scientific literature and expert consensus, only studies with ≥ 7 measurement days and ≥ 4 valid days of ≥ 8 h of monitoring were included in the primary analysis. RESULTS: Thirty-seven of 110 (34%) identified studies fulfilled the criteria, investigating the efficacy and/or effectiveness of physical activity behavior change programs (n = 7), mobile or electronic-health interventions (n = 9), rehabilitative exercise (n = 9), bronchodilation (n = 6), lung volume reduction procedures (n = 3), and other interventions (n = 3). Results are generally variable, reflecting the large differences in study characteristics and outcomes. Few studies show an increase beyond the proposed minimal important change of 600 to 1100 daily steps, indicating that enhancing physical activity levels is a challenge. INTERPRETATION: Only one-third of clinical trials measuring objective physical activity in people with COPD fulfilled the preset criteria regarding physical activity assessment. Studies showed variable effects on physical activity even when investigating similar interventions.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Burtin C, Mohan D, Troosters T, et al. Objectively Measured Physical Activity as a COPD Clinical Trial Outcome. Chest. 2021. PMID: 34217679. doi:10.1016/j.chest.2021.06.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。